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Fibreoptic bronchoscopy was performed on 190 patients with chest radiographic lesions and negative sputum smears 
for acid-fast bacilli. Aside from obtaining transbronchial biopsies for histological examination, bronchial aspirate 
specimens were also tested for Mycobacterium tuberculosis complex DNA by a conventional polymerase chain 
reaction (PCR) technique. Of 177 transbronchial biopsies performed, a diagnosis was found in 64 cases [43 cases of 
tuberculosis (TB), 17 cases of lung carcinoma and four cases of other infective/inflammatory diseases] giving a 
diagnostic yield of 36.2%. PCR was positive in 105 of 108 finally diagnosed cases of TB and 22 of 82 non-TB cases. 
The sensitivity, specificity, positive predictive value and negative predictive value of PCR when applied to bronchial 
aspirate specimens for diagnosing smear-negative pulmonary TB were 97.2%, 73.2%, 82.7% and 95.2% respectively. 
Therefore, detection of M tuberculosis complex DNA in bronchial aspirates by PCR might have an adjunctive place 
to transbronchial biopsies in the rapid diagnosis of smear-negative pulmonary tuberculosis. 
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Introduction 
Pulmonary tuberculosis (TB) is an important respiratory 
infection and health problem worldwide. Early diagnosis 
and treatment are important components in the control of 
this infectious disease. Direct smear examination of sputum 
is a simple and rapid diagnostic method but is limited by 
low sensitivity. Therefore, other methods of rapid diagnosis 
of smear-negative TB have become areas of intense research 
in recent years. Fibreoptic bronchoscopy has been reported 
to be useful in the early diagnosis of TB by histological 
examination of transbronchial biopsies (l-3). In recent 
years, a new diagnostic technique by the detection of DNA 
of Mycobacterium tuberculosis complex after amplification 
by polymerase chain reaction (PCR) has been widely 
reported (4-l 1). 
In this study, we investigated the application of PCR in 
bronchial aspirate specimens as an adjunct to transbron- 
chial biopsies in the rapid diagnosis of smear-negative TB. 
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Patients and Methods 
One hundred and ninety patients with or without respirat- 
ory symptoms were enrolled into this study. They all had 
lesions on chest radiographs, for which pulmonary TB 
was a differential diagnosis. All patients also had sputum 
negative for acid-fast bacilli by direct microscopy on at 
least two occasions. Fibreoptic bronchoscopy was per- 
fdrmed on these patients. In addition to obtaining trans- 
bronchial biopsies for histological examinations and saving 
bronchial aspirates for cytological examinations and myco- 
bacterial culture, about 5 ml of bronchial aspirates were 
saved and sent for PCR study. The results of the PCR study 
were correlated retrospectively with the final diagnoses 
reached. 
FIBREOPTIC BRONCHOSCOPY PROCEDURE 
The investigations were performed by experienced physi- 
cians. Bronchoscopy was done by a transoral or transnasal 
route using a Pentax SBlSX fibreoptic bronchoscope. 
Patients were premeditated with atropine 0.3 to 0.6 mg and 
pethidine 30 to 50 mg i.m. Lignocaine hydrochloride was 
used for topical anaesthesia of the larynx and tracheobron- 
chial tree. After examination of these structures, normal 
saline was instilled into the orifices of the bronchopulmo- 
nary segments at which the lesion was likely to be located, 
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and was then aspirated back. Transbronchial lung biopsy 
was taken from the same bronchopulmonary segments. 
MYCOBACTERIAL EXAMINATION METHOD 
OF THE BRONCHIAL ASPIRATE SPECIMENS 
A modified Petroff method was used for the mycobacterial 
culture of the bronchial aspirate specimens. After sodium 
hydroxide decontamination and neutralization, the speci- 
men was centrifuged at 3000 g for 20 min and two loopsful 
of the sediment was directly inoculated into the 
Lowenstein-Jensen medium. The medium was examined 
weekly for up to 12 weeks. Identification and drug 
susceptibility tests were done for positive cultures. 
PREPARATION OF THE BRONCHIAL ASPIRATE 
SPECIMEN AND EXTRACTION OF DNA FOR 
PCR 
Bronchial aspirate specimens (0.5 ml) were pretreated with 
1.0 ml 4% (w/v) sodium hydroxide, shaken at 2500 rpm for 
25 min, 1.5 ml penicillin water (0.2 IU ml ~ ‘) was added, 
mixed and centrifuged at 5000 g for 20 min. The super- 
natant was discarded and the pellet was washed twice with 
2.0 ml penicillin water, and then resuspended in I.0 ml 
1 x TE buffer. Lysozyme was then added to the suspension, 
mixed, and incubated at 37°C for 1 h. The solution was 
further mixed with 70 ml of sodium dodecyl sulphate and 
6~1 of Proteinase K, incubated at 65°C for 10 min, 
before the addition of 100 ml of 5 M NaCl. Eighty ~1 of 
N-cetyl-N,N,N,-trimethyl ammonium bromide/NaCl 
mixture was then added and vigorously mixed with the 
mixture. DNA was then extracted from the milky 
mixture by equal volume of chloroform : isoamyl alcohol 
(24: 1, v/v). After centrifugation, the supernatant was trans- 
ferred to a fresh microcentrifuge tube. Isopropanol was 
then added to precipitate the DNA. After centrifugation, 
the DNA pellet was then washed with cold ethanol, re- 
pelleted by centrifugation and finally dissolved in distilled 
water until used. 
POLYMERASE CHAIN REACTION/TECHNIQUE 
A pair of 20-base synthetic oligonucleotides that flank 
a 245-base region of insertion sequence IS6110/986 for 
M. tuberculosis was synthesized. The sequences of the 
oligonucleotide primers were: 
S’CGTGAGGGCATCGAGGTGGC3’ and 
S’GCGTAGGCGTCGGTGACAAA3’ 
Another oligonucleotide pair .of 20 bases in length 
located between the two primers was synthesized to be used 
as the hybridization probes and their sequences were: 
SGAACGGCTGATGACCAAACT3 and 
S’ACGTAGGCGAACCCTGCCCA3’ 
Both the oligonucleotide primers and probes were syn- 
thesized using an oligonucleotide synthesizer (Millipore) 
using the reagents supplied by the same company. 
DNA amplification was performed in a final volume of 
50~1 which contained 10 mM Tris-HCl (pH 8.3), 50 mM 
KCl, 1.5 mM MgCl,, 0.001% gelatin, 20~1 1.25 mM (each) 
deoxynucleoside triphosphates, 1U of Taq polymerase, 
10 ~1 of the extracted DNA and 200 ng of each oligonucleo- 
tide primers. The reaction was performed in an automated 
thermal cycler. The amplification procedure was initiated 
by denaturation at 94°C for 3 min, followed by 30 cycles at 
94°C for 1 min, 65°C for 1 min, 72°C for 2 min, and finally 
elongation at 72°C for 4 min. 
15~1 of the PCR products were examined under UV 
illumination in the form of electrophoretic spread in 0.8% 
agarose gel with ethidium bromide staining. The 245 bp 
band identified was separated by electrophoresis and 
processed by Southern blotting and hybridization with 
the labeled 20 bp oligonucleotide probes homologous to the 
middle portion of the insertion sequence IS61101986. 
The hybridized products were viewed with a chemilumines- 
cence system (ECL system) for identification of the M. 
tuberculosis DNA. 
To avoid contamination, the DNA extraction, PCR, and 
electrophoresis procedures were performed in three separ- 
ate laboratories. Reagents for every step were thoroughly 
checked and sterilized. Positive control using DNA 
extracted from MTB H37Rv and negative control without 
DNA were employed to monitor the PCR procedure. 
DIAGNOSTIC CRITERIA OF TUBERCULOSIS IN 
THE PATIENTS STUDIED 
Diagnosis of TB was based on histological, bacteriological 
and clinical grounds. Based on different evidences, TB 
patients can be divided into the following categories: those 
with: 
(a) a positive transbronchial biopsy showing the presence 
of granulomatous inflammation with or without demon- 
strable acid-fast bacilli; and a positive culture of the 
bronchial aspirate andlor sputum for A4 tuberculosis. 
(b) only a positive transbronchial biopsy showing the 
presence of granulomatous inflammation with or without 
stainable acid-fast bacilli. 
(c) only a positive culture of the bronchial aspirate and/or 
sputum for 44 tuberculosis. 
(d) none of the above, but with the diagnosis of TB 
confirmed by other investigative procedures such as needle 
biopsy or open biopsy of the lung. 
(e) none of the above, but with the diagnosis of TB made 
on clinical and radiological grounds only. 
Most importantly, patients in all groups showed 
improvement with anti-tuberculous drug treatment. 
Results 
Two hundred patients were enrolled into the study. Ten 
patients were lost to follow-up and the final diagnosis could 
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TABLE 1. Demographic data of 190 studied patients 
Gender 
Male 
Female 
Age 
no. (%) 
146 (768%) 
44 (23.2%) 
Range 15-80 years 
Mean 51.5 years 
Ethnic group no. (%) 
Chinese 188 (99%) 
Filipino 1 (0.5%) 
Indian 1 (0.5%) 
TABLE 2. Results of transbronchial biopsies 
Diagnosis Number 
Tuberculosis 
Carcinomas 
Bronchiolitis obliterans and organizing 
pneumonia 
Cryptococcosis 
Actinomycosis 
Aspergillosis 
Non-diagnostic 
Total 
43 
17 
1 
1 
1 
1 
113 
177 
not be ascertained and they were thus excluded. The results 
of the remaining 190 cases were analysed. The demographic 
data of these patients are as shown in Table 1. 
All patients underwent fibreoptic bronchoscopy. Trans- 
bronchial biopsies were not done in 13 cases because of 
severely compromised lung function. There was no mor- 
tality or significant morbidity associated with the pro- 
cedure. Out of the 177 transbronchial biopsies, a conclusive 
diagnosis was obtained in 64 cases giving a diagnostic yield 
of 36.2% (Table 2). 
Based on the diagnostic criteria alluded to earlier, a final 
diagnosis of TB was reached in 108 of the 190 cases studied. 
PCR was positive in 105 cases. In the remaining 82 
non-tuberculous patients, PCR was positive in 22 cases 
(Table 3). The overall sensitivity, specificity, positive and 
negative predictive values of PCR in the diagnosis of TB 
were 97.2%, 73.2%, 82.7% and 95.2% respectively. 
Among the 17 cases with transbronchial biopsies that 
yielded lung carcinoma, two of them subsequently had 
bronchial aspirates that yielded A4. tuberculosis on culture. 
These latter patients had concomitant lung cancer and 
pulmonary TB. The bronchial aspirates for PCR were also 
positive in these two cases. 
In the group of non-TB patients, 12 of 22 PCR positive 
cases had radiographic evidence of previous TB. This 
proportion seemed to be higher when compared with the 
PCR negative group (22 of 60) but the difference hasnot 
reached statistical significance (x2 test, P=O.O7). 
Discussion 
The diagnosis of smear-negative TB is both a common and 
important clinical problem. In areas of high prevalence of 
TB like Hong Kong, TB is often the cause of persistent 
chest radiograph lesions. However, other conditions, lung 
carcinoma in particular, have to be considered as alterna- 
tive diagnoses. Empiric TB treatment for radiographic 
lesions may carry a risk of delaying the diagnosis and 
administration of appropriate treatment for the non-TB 
disorders. 
The usefulness of fibreoptic bronchoscopy in the diagno- 
sis of sputum smear-negative TB has been well reported 
(l-3). It is a simple, safe and cost-effective procedure. A 
definitive diagnosis could be reached in over 90% of cases 
by combining histological and mycobacteriological study of 
specimens obtained (1,2). Transbronchial biopsy, apart 
from its usefulness in rapid diagnosis of TB, is also 
important in diagnosing other pulmonary diseases like lung 
carcinoma. In our study, the diagnostic yield of trans- 
bronchial biopsy in pulmonary tuberculosis was found to 
be 43008 (39.8%) corroborating with findings of other 
series (1,2). On the other hand, examination for acid-fast 
bacilli by direct microscopy using bronchial aspirate 
and bronchial brush specimens has produced quite variable 
TABLE 3. Results of PCR in bronchial aspirates in 190 patients studied 
[al PI 
TB 
[cl VI M 
Non-TB 
cases 
PCR (+) 31 10 31t 8 25 22 (12)” 
PCR(-) 2 0 0 0 1 60 (22)” 
[a] positive transbronchial biopsy+positive MTB culture. 
[b] positive transbronchial biopsy only. 
[c] positive MTB culture only. 
[d] diagnosis made by other investigations. 
[e] clinical and radiological diagnosis. 
( )* number of patients with evidence of previous pulmonary tuberculosis. 
Tincluding two patients with concomitant TB and lung cancer. 
818 C. F. WONG ET AL. 
yields (l-3). Such examinations were not investigated in this 
study. 
PCR is a new molecular biology technique which has 
widespread clinical applications in medicine (4). The pres- 
ence of an infective agent in the clinical specimens can be 
demonstrated by its DNA sequence after amplification. The 
insertion sequence IS61 lo/986 has been found to be specific 
for M. tuberculosis complex which allows differentiation 
from other non-tuberculous mycobacteria (5). Since the 
early 1990s numerous studies on diagnosis of TB using 
PCR technique from various centres have been published. 
The reported sensitivity was in general very high. However, 
the sensitivity becomes much lower when only smear- 
negative cases are considered. Clarridge examined over 
5000 respiratory specimens among which 2 18 were positive 
for M tuberculosis. PCR was positive in 83.5% of these 
cases. However, it was positive in 62% (45 of 73) of 
smear-negative cases (8). Similar results were found in a 
study by Nolte in which the sensitivity of PCR in the 
diagnosis of tuberculosis was 95% (105 of 110) but in 
smear-negative cases, PCR was positive in only eight of 14 
(57%) (9). In our study, the sensitivity of PCR in diagnosis 
of TB was found to be very high. Bronchial aspirates, the 
specimens examined, were taken directly from the broncho- 
pulmonary segments in which the lesions were located. This 
may result in a better yield than examining sputum speci- 
mens, as the latter are more liable to be confounded with 
sampling bias. The attendant low specificity of the PCR test 
in our patients studied is unsatisfactory and requires further 
investigation and explanation. We conjecture that the 
rather sensitive PCR technique might also amplify DNA 
from very small number of dormant tubercle bacilli from 
the inactive TB lesions and gave rise to false-positive 
results. Although this possible cause for false-positive PCR 
results has not been properly studied, it has also been noted 
in some other studies. For example, in a study by Schluger, 
PCR was positive in 12 of 17 patients with a prior history of 
tuberculosis but no active pulmonary TB (10). Similarly, 
Querol found false-positive PCR in 10 of 44 patients with 
old pulmonary TB (11). About the usefulness of PCR when 
applied by routine clinical practice, Grosset and Mouton 
opined in a journal’s editorial that PCR by itself should not 
be used as a rapid diagnostic tool for TB because of 
insufficient reliability (12). 
Another genuine limitation to the routine use of PCR in 
diagnosis of TB is its high cost. Although the cost of a PCR 
test ranges widely (from about $7 US for in-house PCR to 
about $30 US for PCR by commercial kits), this is certainly 
prohibitive for routine application of the technique for 
diagnosis of TB for developing countries. 
Finally, the diagnosis of TB by PCR does not exclude the 
presence of another pathology, especially when the preva- 
lence of both diseases are high. This has been alluded to 
under the Results section for the two cases of concomitant 
TB and lung carcinoma. 
Conclusion 
Our study has demonstrated again, as has been previously 
shown, that bronchoscopy with transbronchial biopsy is 
very useful in the rapid diagnosis of smear-negative TB. 
PCR, the new molecular biology technique which has been 
studied in recent years, also has a definite role in the rapid 
diagnosis of TB. It might have an adjunctive role to 
transbronchial biopsy in a clinical setting. We suggest 
bronchoscopy and transbronchial biopsies to be done in 
sputum smear-negative patients for rapid diagnosis of TB 
and to exclude other pathology for undiagnosed lung 
lesions. In those cases when transbronchial biopsies are 
non-diagnostic or cannot be done because of severely 
compromised lung function, a PCR test of the bronchial 
aspirate specimens collected could be a useful adjunct in the 
early diagnosis of TB. 
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